Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through highly accurate quantification of tissue fat and iron from MRI scans.
Mar 24 2024Quibim It has been given a CE and UKCA mark for the European Union and United Kingdom respectively, meaning it is cleared to be used in those markets.
The platform features a post-processing solution for fat and iron quantification that performs fully automatic analyses of abdominal MRI examinations containing multi-echo chemical shift sequences that can precisely detect and quantify fat content. It can then generate parametric maps of fat and iron, offering detailed analysis by processing each tiny 3D element of the scan individually to generate what is known as voxel-wise resolution.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Overeating and starving both damage the liver: Cavefish provide new insight into fatty liver diseaseFatty liver, which can lead to liver damage and disease, can occur from both overeating and starvation. Now, new research shows how naturally starvation-resistant cavefish, unlike other animals, are able to protect their liver and remain healthy. The findings have implications for understanding and potentially addressing liver conditions in humans.
続きを読む »
Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancerFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease is caused by a single genetic mutation that creates a fusion protein. Scientists at St.
続きを読む »
Immune evasion tactics of liver cancer cells revealedA faulty cancer gene helps tumors evade immunity by stopping tumor cells releasing message-containing cargoes called exosomes.
続きを読む »
Intermittent food intake activates a 'GPS gene' in liver cells, thus completing the development of the liver after birthIn mammals, the liver detects the body's energy demand at any given moment and mobilizes nutrient reserves to meet it. It is a vital function that is subdivided into multiple tasks: from releasing glucose into the blood when the hormone insulin alerts about a need for energy, to synthesizing essential fats or proteins.
続きを読む »
Experts help bring first-of-its-kind drug for metabolic liver disease to the clinicLiver disease specialists at the University of Chicago Medicine will soon begin prescribing a first-of-its-kind drug for treating advanced metabolic dysfunction-associated steatotic liver disease (MASLD)—formerly known as nonalcoholic fatty liver disease (NAFLD).
続きを読む »
Longitudinal gut fungal alterations and potential fungal biomarkers for the progression of primary liver diseaseScience China Life Sciences has reported on the research results of Lanjuan Li's team from Zhejiang University. Recent advances in microbiome research have revealed complex changes in gut microecology across various disease states, highlighting their profound impact on disease progression.
続きを読む »